• 1. Huffman J, Kossoff EH. State of the ketogenic diet(s) in epilepsy. Curr Neurol Neurosci Rep 2006; 6: 332340.

  • 2. Liu YM, Wang HS. Medium-chain triglyceride ketogenic diet, an effective treatment for drug-resistant epilepsy and a comparison with other ketogenic diets. Biomed J 2013; 36: 915.

    • Search Google Scholar
    • Export Citation
  • 3. Tagliabue A, Bertoli S, Trentani C, et al. Effects of the ketogenic diet on nutritional status, resting energy expenditure, and substrate oxidation in patients with medically refractory epilepsy: a 6-month prospective observational study. Clin Nutr 2012; 31: 246249.

    • Search Google Scholar
    • Export Citation
  • 4. Cunnane SC, Musa K, Ryan MA, et al. Potential role of polyunsaturates in seizure protection achieved with the ketogenic diet. Prostaglandins Leukot Essent Fatty Acids 2002; 67: 131135.

    • Search Google Scholar
    • Export Citation
  • 5. Cullingford TE. The ketogenic diet; fatty acids, fatty acid-activated receptors and neurological disorders. Prostaglandins Leukot Essent Fatty Acids 2004; 70: 253264.

    • Search Google Scholar
    • Export Citation
  • 6. Eagles DA. Design of dietary treatment: humans versus rodents. Epilepsia 2008; 49 (suppl 8): 6163.

  • 7. Crandall LA. A comparison of ketosis in man and dog. J Biol Chem 1941; 138: 123128.

  • 8. de Bruijne JJ, van den Brom WE. The effect of long-term fasting on ketone body metabolism in the dog. Comp Biochem Physiol B 1986; 83: 391395.

    • Search Google Scholar
    • Export Citation
  • 9. Puchowicz MA, Smith CL, Bomont C, et al. Dog model of therapeutic ketosis induced by oral administration of R, S-1, 3-butanediol diacetoacetate. J Nutr Biochem 2000; 11: 281287.

    • Search Google Scholar
    • Export Citation
  • 10. Bergqvist AG, Schall JI, Stallings VA, et al. Progressive bone mineral content loss in children with intractable epilepsy treated with the ketogenic diet. Am J Clin Nutr 2008; 88: 16781684.

    • Search Google Scholar
    • Export Citation
  • 11. Christodoulides SS, Neal EG, Fitzsimmons G, et al. The effect of the classical and medium chain triglyceride ketogenic diet on vitamin and mineral levels. J Hum Nutr Diet 2012; 25: 1626.

    • Search Google Scholar
    • Export Citation
  • 12. Kang HC, Chung DE, Kim DW, et al. Early- and late-onset complications of the ketogenic diet for intractable epilepsy. Epilepsia 2004; 45: 11161123.

    • Search Google Scholar
    • Export Citation
  • 13. Yuasa M, Matsui T, Ando S, et al. Consumption of a low-carbohydrate and high-fat diet (the ketogenic diet) exaggerates biotin deficiency in mice. Nutrition 2013; 29: 12661270.

    • Search Google Scholar
    • Export Citation
  • 14. National Research Council Ad Hoc Committee on Dog and Cat Nutrition. Nutrient requirements and dietary nutrient concentration. In: Nutrient requirements of dogs and cats. Washington, DC: National Academy Press, 2006; 354370.

    • Search Google Scholar
    • Export Citation
  • 15. Govendir M, Perkins M, Malik R. Improving seizure control in dogs with refractory epilepsy using gabapentin as an adjunctive agent. Aust Vet J 2005; 83: 602608.

    • Search Google Scholar
    • Export Citation
  • 16. Kluger EK, Malik R, Ilkin WJ, et al. Serum triglyceride concentration in dogs with epilepsy treated with phenobarbital or with phenobarbital and bromide. J Am Vet Med Assoc 2008; 233: 12701277.

    • Search Google Scholar
    • Export Citation
  • 17. Hess RS, Kass PH, Shofer FS, et al. Evaluation of risk factors for fatal acute pancreatitis in dogs. J Am Vet Med Assoc 1999; 214: 4651.

    • Search Google Scholar
    • Export Citation
  • 18. Gaskill CL, Cribb AE. Pancreatitis associated with potassium bromide/phenobarbital combination therapy in epileptic dogs. Can Vet J 2000; 41: 555558.

    • Search Google Scholar
    • Export Citation
  • 19. Stenier JM, Xenoulis PG, Anderson JA, et al. Serum pancreatic lipase immunoreactivity concentrations in dogs treated with potassium bromide and/or phenobarbital. Vet Ther 2008; 9: 3744.

    • Search Google Scholar
    • Export Citation
  • 20. Hess RS, Saunders HM, Van Winkle TJ, et al. Clinical, clinic-pathologic, radiographic, and ultrasonographic abnormalities in dogs with fatal acute pancreatitis: 70 cases (1986–1995). J Am Vet Med Assoc 1998; 213: 665670.

    • Search Google Scholar
    • Export Citation
  • 21. Maguire PJ, Fettman MJ, O'Smith MO, et al. Effects of diet on pharmacokinetics of phenobarbital in healthy dogs. J Am Vet Med Assoc 2000; 217: 847852.

    • Search Google Scholar
    • Export Citation
  • 22. Apovian CM. The clinical and economic consequences of obesity. Am J Manag Care 2013; 19 (suppl 11): s219s228.

  • 23. Hanley MJ, Abernethy DR, Greenblatt DJ. Effect of obesity on the pharmacokinetics of drugs in humans. Clin Pharmacokinet 2010; 49: 7187.

    • Search Google Scholar
    • Export Citation
  • 24. Wilkes L, Danziger LH, Rodvold KA. Phenobarbital pharmacokinetics in obesity. A case report. Clin Pharmacokinet 1992; 22: 481484.

  • 25. Wuerzner G, Bochud M, Giusti V, et al. Measurement of glomerular filtration rate in obese patients: pitfalls and potential consequences on drug therapy. Obes Facts 2011; 4: 238243.

    • Search Google Scholar
    • Export Citation
  • 26. Wright C, Downing J, Mungall D, et al. Clinical pharmacology and pharmacokinetics of levetiracetam. Front Neurol 2013; 4: 16.

  • 27. Brodie MJ, Ben-Menachem E, Chouette I, et al. Zonisamide: its pharmacology, efficacy and safety in clinical trials. Acta Neurol Scand Suppl 2012; 194: 1928.

    • Search Google Scholar
    • Export Citation
  • 28. Kealy RD, Lawler DF, Ballam JM, et al. Effects of diet restriction on life span and age-related changes in dogs. J Am Vet Med Assoc 2002; 220: 13151320.

    • Search Google Scholar
    • Export Citation
  • 29. Fukunaga K, Saito M, Muto M, et al. Effects of urine pH modification on pharmacokinetics of phenobarbital in healthy dogs. J Vet Pharmacol Ther 2008; 31: 431436.

    • Search Google Scholar
    • Export Citation
  • 30. Kielb S, Koo HP, Bloom DA, et al. Nephrolithiasis associated with the ketogenic diet. J Urol 2000; 164: 464466.

  • 31. Vernau KM, LeCouteur RA. Anticonvulsant drugs. In: Maddison JE, Page SW, Church DB, eds. Small animal clinical pharmacology. 2nd ed. Philadelphia: Elsevier Ltd, 2008; 367379.

    • Search Google Scholar
    • Export Citation
  • 32. Chandler K. Treatment and monitoring of epilepsy in dogs. In Pract 2011; 33: 98104.

  • 33. Shaw N, Trepanier LA, Center SA, et al. High dietary chloride content associated with loss of therapeutic serum bromide concentrations in an epileptic dog. J Am Vet Med Assoc 1996; 208: 234236.

    • Search Google Scholar
    • Export Citation
  • 34. Trepanier LA, Babish JG. Effect of dietary chloride content on the elimination of bromide by dogs. Res Vet Sci 1995; 58: 252255.

  • 35. Baird-Heinz HE, Van Schoick AL, Pelsor FR, et al. A systematic review of the safety of potassium bromide in dogs. J Am Vet Med Assoc 2012; 240: 705715.

    • Search Google Scholar
    • Export Citation
  • 36. Trepanier LA. Use of bromide as an anticonvulsant for dogs with epilepsy. J Am Vet Med Assoc 1995; 207: 163166.

  • 37. Rosser EJ. Diagnosis of food allergy in dogs. J Am Vet Med Assoc 1995; 203: 259262.

  • 38. Frediani T, Pelliccia A, Aprile A, et al. Partial idiopathic epilepsy: recovery after allergen-free diet. Pediatr Med Chir 2004; 26: 196197.

    • Search Google Scholar
    • Export Citation
  • 39. Strine TW, Kobau R, Chapman DP. Psychological distress, comorbidities, and health behaviors among U.S. adults with seizures: results from the 2002 National Health Interview Survey. Epilepsia 2005; 46: 11331139.

    • Search Google Scholar
    • Export Citation
  • 40. Silverberg JI, Joks R, Durkin HG. Allergic disease is associated with epilepsy in childhood: a US population-based study. Allergy 2014; 69: 95103.

    • Search Google Scholar
    • Export Citation
  • 41. Anderson GJ, Conner WE, Corliss JD. Docosahexaenoic acid is the preferred dietary n-3 fatty acid for the development of the brain, retina. Pediatr Res 1990; 27: 8997.

    • Search Google Scholar
    • Export Citation
  • 42. Ferrari D, Cysneiros RM, Scorza CA, et al. Neuroprotective activity of omega-3 fatty acids against epilepsy-induced hippocampal damage: quantification with immunohistochemical for calcium-binding protein. Epilepsy Behav 2008; 13: 3642.

    • Search Google Scholar
    • Export Citation
  • 43. Bauer JE. Therapeutic use of fish oils in companion animals. J Am Vet Med Assoc 2011; 239: 14411451.

  • 44. Bellissimo MI, Amado D, Abdalla DS, et al. Superoxide dismutase, glutathione peroxidase activities and the hydroperoxide concentration are modified in the hippocampus of epileptic rats. Epilepsy Res 2001; 46: 121128.

    • Search Google Scholar
    • Export Citation
  • 45. Naffah-Mazzacoratti MG, Bellíssimo MI, Cavalheiro EA. Profile of prostaglandin levels in the rat hippocampus in pilocarpine model of epilepsy. Neurochem Int 1995; 27: 461466.

    • Search Google Scholar
    • Export Citation
  • 46. Scorza FA, Cavalheiro EA, Arido RM, et al. Positive impact of omega-3 fatty acid supplementation in a dog with drug-resistant epilepsy: a case study. Epilepsy Behav 2009; 15: 527528.

    • Search Google Scholar
    • Export Citation
  • 47. Matthews H, Grander N, Wood J, et al. Effects of essential fatty acid supplementation in dogs with idiopathic epilepsy: a clinical trial. Vet J 2012; 191: 396398.

    • Search Google Scholar
    • Export Citation
  • 48. Bauer JE. Evaluation and dietary consideration in idiopathic hyperlipidemia in dogs. J Am Vet Med Assoc 1995; 206: 16841688.

  • 49. Oja SS, Saransaari P. Taurine and epilepsy. Epilepsy Res 2013; 104: 187194.

  • 50. Ripps H, Shen W. Taurine: a “very essential” amino acid. Mol Vision 2010; 18: 26732686.

  • 51. Tanizawa K, Mizuno T, Ueda K, et al. Taurine treatment for spontaneous epilepsy in the cat. Jpn J Vet Sci 1986; 48: 10411043.

  • 52. van Gelder NM, Koyama I, Jasper HH. Taurine treatment of spontaneous chronic epilepsy in a cat. Epilepsia 1977; 18: 4554.

  • 53. van Gelder NM, Edmonds HL, Hegreberg GA, et al. Amino acid changes in a genetic strain of epileptic Beagle dogs. J Neurochem 1980; 35: 10871091.

    • Search Google Scholar
    • Export Citation
  • 54. Volk HA, Davies E. Trial of a novel diet for epilepsy in dogs. Vet Rec 2013; 172: 319320.

Advertisement

Nutritional management of idiopathic epilepsy in dogs

View More View Less
  • 1 Department of Molecular Biosciences, School of Veterinary Medicine, University of California-Davis, Davis, CA 95616.
  • | 2 Veterinary Medical Teaching Hospital, School of Veterinary Medicine, University of California-Davis, Davis, CA 95616.
  • | 3 Department of Molecular Biosciences, School of Veterinary Medicine, University of California-Davis, Davis, CA 95616.

Contributor Notes

Address correspondence to Dr. Larsen (jalarsen@vmth.ucdavis.edu).